Vaccines A-Z

Precision Vaccinations

 / November 20th, 2024

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Vaccine News

Nov 20 • 10:09 am CST

Bladder Cancer Immunotherapy Reports Response Rate of 71% with a Durable Duration of Response Ranging Up to 54 Months

ImmunityBio, Inc. recently announced compelling new data from its ongoing QUILT 3.032 study. As of November 2024, 100 patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer with carcinoma in situ (NMIBC CIS) have been treated... READ →
Nov 20 • 5:23 am CST

HIV-1 Protein Nanoparticle Vaccine Candidate Reported Safe and Well-tolerated in Phase 1 Clinical Trial

Uvax Bio, LLC today announced the interim analysis results from its first Phase 1 clinical trial evaluating the Company’s HIV-1 vaccine candidates, UVAX-1107 and UVAX-1197. In the first stage of this trial, the subjects received either... READ →
Nov 19 • 2:51 pm CST

Japan's Mpox Vaccine Listed by the WHO

The World Health Organization (WHO) today announced it has granted Emergency Use Listing (EUL) for the LC16m8 smallpox / mpox vaccine, making it the second mpox vaccine to be supported by WHO. LC16m8 is a vaccine... READ →
Nov 18 • 12:14 pm CST

Visiting Bermuda Does Not Require Vaccination in 2024

When searching for a winter holiday destination in 2024, Bermuda may top the healthy destination list, as no vaccination requirements are currently in effect. This good news helped boost Bermuda's tourism industry in 2023 when arrivals... READ →
Nov 16 • 2:53 pm CST

First Mpox Clade I Case Confirmed in California

The California Department of Public Health (CDPH) today announced it had identified the first known case of clade I mpox in the United States. This case was confirmed in an individual who recently traveled from Africa... READ →

More Breaking News

Hookworm Vaccines Are in Demand

Mpox Vaccine Production Reaches 10 Million Doses

Over 92 Million Flu Shots Delivered

Polio Outbreaks Continue in November 2024

Only 74% of Children Received Second MMR Dose

Passive Immunization Against RSV Found 89% Effective in Infants

Mpox Vaccine Candidate Found Less Virulent

Immunotherapy in Early Parkinson’s Disease Posts Positive Interim Results from Phase 2 Study

Tuberculosis Continues Infecting People in Africa

Texas Reports 772 Pertussis Cases in 2024

Latest Vaccine Breaking News

Lyme disease Parasitizing Birds Bring More than Lyme Disease Lyme disease vaccine candidate is conducting late stage research
  • Lyme Disease
Oropouche Outbreaks Often Detected Outside Large Cities Oropouche outbreaks 3.9 times greater in small municipalities
  • Oropouche
Pandemic Preparedness Research Network Launched High priority pathogens require protective vaccines
  • Chikungunya
cancer vaccine One-Dose HPV Vaccinations Save More Women from Cervical Cancer 37 countries offer one dose HPV vaccines for young women
vaccine One STD is Decreasing As Off-Label Vaccine Use Increases MenB vaccination reduces gonorrhea infections
dengue vaccine America's Dengue Cases Increase 280% Dengue vaccines are unavailable in the United States in 2024
Shigella Vaccine May Soon Stop Diarrheal Disease Outbreaks Tetravalent Shigella Vaccine Candidate Launches Phase 2b Human Challenge Study
Argentina Changes History, Confronts Chikungunya Outbreak with Sterile Mosquitoes Chikungunya is a vaccine preventable disease
measles Measles Outbreaks Can Be Eliminated Travel vaccinations reduce measles outbreaks in 2024
TB vaccine Can Children Access Tuberculosis Vaccines Tuberculosis vaccination approved for children in various countries
dengue Southern California's Dengue Outbreak Reaches San Bernardino County Local dengue infections in Los Angeles, San Bernardino, San Diego counties in 2024
Pennsylvania Leads U.S. Pertussis Outbreak Pertussis Cases Increase 500% in 2024
vaccine Chikungunya Outbreaks Approaching Unfortunate Record in 2024 Chikungunya disease is vaccine preventable
Malaria Day in the Americas 2024 Malaria is a vaccine preventable disease
vaccine Chikungunya Symptoms Detected Seven Years Later Chikungunya vaccine commercially available in 2024
vaccine Shigellosis Vaccine Needed in Africa
Is Dengue Endemic in Los Angeles
malaria Malaria Vaccine Changed the Game, Awarded Innovation of the Year
dengue Second Generation Dengue Vaccine Produces Durable T-Cell Protection
Chikungunya Outbreaks Could be 60 Times More Fatal
vaccine Tuberculosis Killed 1.25 Million People Globally
dengue Dengue Outbreak Undercounting Revealed
UTI vaccine Second Oral UTI Treatment Approved, But Still No Vaccine
Smartphones Help Identify Which Mosquitoes Carry Which Virus
poliovirus The World is Not Polio Free Today
vaccine U.S. CDC Confirms Chikungunya Vaccine's 97% Seroresponse Rate
NWS Will New World Screwworms Return to the U.S.
Hajj Pilgrim Vaccine Certification Capability Expanded
vaccine Which Vectors Drive Oropouche Fever Transmission in the Americas
cholera Global Cholera Vaccine Stockpile is Depleted
Chikungunya Sets Unfortunate Records in 2024
vaccine Vaccination Protects Diwali Travelers from Disease
vaccine Shigella Vaccine Candidate Awarded U.S. FDA Fast Track Designation
Chikungunya vaccine Approved Chikungunya Vaccine Confirmed Safe and Effective
Shigella Vaccine Candidate Advancing in Clinical Trials

For more articles, try our search.